Involving the aorta and any of its major branches, Giant Cell Arteritis (GCA) is a heterogeneous systemic granulomatous vasculitis. Despite improved understanding regarding large vessel (LV) involvement, reports on the incidence, clinical presentations, and complications of large vessel giant cell arteritis (LV-GCA) demonstrate inconsistent findings, a consequence of diverse criteria for defining the disease, methodological differences between studies, and the wide spectrum of clinical manifestations. The objective of this systematic literature review was to better define LV-GCA using the available research and uncover characteristic distinctions that set LV-GCA patients apart from those experiencing limited cranial disease.
The retrieval of published research papers indexed in MEDLINE and EMBASE, from their commencement to May 7th, 2021, constituted a comprehensive literature search. Cohort or cross-sectional studies featuring at least 25 patients with LV-GCA were incorporated into the analysis. To include control groups, the dataset required data points from patients with limited cranial GCA (C-GCA). Data synthesis, quantitative in nature, was performed using Stata with a random effects meta-regression model.
Of the 3488 studies resulting from the search, 46 were determined to meet the specified criteria for inclusion. There was a disparity in the diagnostic criteria for LV-GCA among different research papers, typically determined by imaging or histopathological evaluations. A notable difference in patient demographics was observed, with LV-GCA patients being diagnosed at a significantly younger age (-453 years on average) compared to C-GCA patients. Moreover, a substantial delay in diagnosis (303 months) was also noted for LV-GCA patients and a lower rate of positive temporal artery biopsies (OR 0.52 [95% CI 0.3, 0.91]). Fewer LV-GCA patients presented with cranial manifestations, with a mere 53% achieving conformity with the 1990 ACR classification criteria for giant cell arteritis. Vasculitis displays a predilection for the thoracic aorta, descending to the subclavian, brachiocephalic trunk, and ultimately the axillary arteries. By the 12-month point, the mean cumulative dose of prednisolone in LV-GCA patients stood at 60,565 milligrams; remarkably, relapse rates were equivalent in both LV- and C-GCA patients; and a sobering 12 percent of deaths within the LV-GCA patient group were a direct outcome of LV complications.
Compared to patients with C-GCA, LV-GCA patients display specific disease features, leading to alterations in diagnostic methods, treatment plans, and the ongoing surveillance of long-term consequences.
Patients with LV-GCA display contrasting disease presentations compared to C-GCA, leading to differing diagnostic criteria, treatment protocols, and long-term monitoring strategies for sequelae.
Neuropsychiatric (NP) involvement in juvenile-onset systemic lupus erythematosus (jSLE) is a distinct, restricted domain.
An exploration of the prevalence, patient characteristics, and neurological manifestations, and the clinical outcomes of neurological complications in the Turkish systemic lupus erythematosus population.
Utilizing SLE cohorts from 24 referral centers, forming a multicenter, multidisciplinary network in Turkey, this study was undertaken. Patient data were meticulously compiled using a case report form, which was rigorously standardized for rheumatological definitions per the criteria of the American College of Rheumatology (ACR). The neuropsychiatric damage was gauged using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)'s neuropsychiatric part. Hierarchical clustering analyses, performed using the Ward method, along with univariate and multivariate logistic regression analyses, were employed to evaluate the variables.
Among 1107 jSLE patients, 149 cases showed involvement of the NP (135% incidence). The most common neurological symptoms linked to NPSLE were headache (503%), seizure (383%), and acute confusional state (336%). From the complete data of clinical and laboratory findings, five clusters were categorized. Within the initial two clusters, neuropathies, demyelinating diseases, aseptic meningitis, and movement disorders were prevalent. In Cluster 3, headache, activity markers, and other manifestations of systemic lupus erythematosus (SLE) were observed. Acute confusional state was located in the fifth cluster, while idiopathic intracranial hypertension, cerebrovascular disease, cognitive dysfunction, psychiatric disorders, and SLE antibodies were grouped together in the fourth cluster. Multivariate analysis revealed an association between APA positivity (OR 2820, 95% CI 1002-7939, p=0.0050), plasmapheresis (OR 13804, 95% CI 2785-68432, p=0.0001), and SLEDAI scores (OR 1115, 95% CI 1049-1186, p=0.0001) and an increased risk of neurologic sequelae.
In Turkey, we observed a high occurrence of juvenile NPSLE symptoms. We've pinpointed five clusters, which might provide crucial understanding of the pathogenesis, treatment, and prognosis surrounding NP involvement. We also identified the factors that contribute to neurological sequelae. Our investigation revealed a necessity for novel definitions of NP involvement and sequelae specific to the childhood period.
Our research in Turkey revealed the prevalence of juvenile manifestations of systemic lupus erythematosus (NPSLE). Five clusters are presented, with the potential to provide understanding of the pathogenesis, treatment, and prognosis in cases of NP involvement. We further investigated the risk factors associated with neurological sequelae. Our study's findings underscore the need for new definitions encompassing NP involvement and sequelae during childhood.
To assess the diagnostic efficacy of visual caries detection on 3D dental models generated by intraoral scanners, and to contrast this with the outcomes of standard clinical visual inspections.
Randomly selected and included in this study were fifty-three permanent posterior teeth planned for extraction. Each tooth's occlusal surface was subject to clinical inspection at one to three independent sites using ICDAS criteria. Intraoral scanning, performed on the examined teeth with a 3D intraoral scanner (TRIOS 4, 3Shape TRIOS A/S, Copenhagen, Denmark), utilized white and blue-violet light (415 nm wavelength) to acquire the color and fluorescence emissions from the dental tissues. Using modified ICDAS criteria, the same examiner, six months post-clinical examination, performed an on-screen assessment of the obtained 3D digital dental models at the selected sites. Both tooth color and fluorescence texture were assessed using high-resolution techniques. To conclude, an independent observer conducted the histological examination of all teeth following their extraction. Considering histology as the definitive measure, sensitivity, specificity, accuracy, the area under the ROC curve, and Spearman's correlation coefficient were assessed for both the in-person and digital ICDAS evaluations.
Initial caries lesions exhibited ACC values ranging from 0.059 to 0.079, while moderate-extensive caries lesions showed values between 0.077 and 0.099. Discrepancies in SE values were limited to caries within the inner enamel layer; clinical visual inspection and on-screen assessment showed no considerable variation. Additionally, the analysis of 3D models, independently of or in conjunction with fluorescence and tooth color, exhibited no difference in any of the diagnostic metrics.
A similar diagnostic accuracy was observed when visually inspecting 3D digital dental models, highlighting tooth color or fluorescence, and when conducting a clinical visual inspection in identifying and classifying occlusal caries lesions on permanent teeth.
3D intraoral scanning is capable of assisting in the detection and classification of occlusal caries within the framework of patient screening, and potentially enables remote caries assessment for use in clinical and research settings.
The use of 3D intraoral scanning can be integral to identifying and classifying occlusal caries, aiding patient screening, and possibly facilitating remote caries assessment in both research and clinical contexts.
Fe, in its pure form, is a potentially biodegradable stent material due to its improved biocompatibility and mechanical characteristics, but its degradation rate presents a significant challenge that demands attention. A prediction is made that the creation of an Fe-Zn alloy through zinc alloying with iron will satisfy the required degradation rate without compromising the unique properties of iron. Fe-Zn alloys were synthesized through the electrodeposition approach, with monolayered and multilayered configurations. We assessed the alloys' composition, microstructure, mechanical properties, in vitro degradation, and biocompatibility. The Zn content, as determined by the results, exhibited a range from 21 wt% to 116 wt%. Following annealing at 450 degrees Celsius, all the alloys were composed of a (Fe) solid solution and a zinc-rich B2 ordered coherent phase; however, the alloy containing 116 wt% zinc exhibited the emergence of a Fe3Zn10 phase. chk signals The layered structure, featuring alternating columnar-grain and nano-grain layers, effectively counteracted the inherent brittleness of electrodeposited metals. This enhancement of the alloy's galvanic effect improved the strength and plasticity, changing corrosion from localized to uniform, and simultaneously increasing the corrosion rate. A corrosion rate of 0.367 mm/year, along with an elongation greater than 20%, and a yield strength surpassing 350 MPa, characterized the multilayered alloy in immersion tests using Hank's solution. Fe-Zn alloys with a lower zinc concentration displayed good cytocompatibility with human umbilical vein endothelial cells and demonstrated a satisfactory blood compatibility. The preceding results show that the multilayered Fe-Zn alloy, prepared via electrodeposition, possessed enhanced mechanical properties, a higher degradation rate, a uniform degradation mechanism, and displayed good biocompatibility. The criteria for using biodegradable stents are met by this application.chk signals
Top comments (0)